Clearance of antitransferrin receptor immunotoxin from the rabbit eye

James Handa, P. Andrew Pearson, Glenn J. Jaffe

Research output: Contribution to journalArticle

Abstract

Purpose. Antitransferrin receptor immunotoxin has potent antiproliferative effects on proliferating human ocular cells in vitro, and shows promise in the treatment of ocular proliferative diseases, such as proliferative vitreoretinopathy, bleb scarring after trabeculectomy, or corneal epithelial downgrowth syndrome. Before treating patients, the pharmacokinetics of immunotoxin must be known. The purpose of this study was to determine the clearance of antitransferrin receptor immunotoxin from the rabbit eye after ocular injection. Methods. Immunotoxin (1,000 ng/0.l ml PBS) was injected into the vitreous cavity of gas vitrectomized rabbit eyes. Immunotoxin in aqueous, vitreous, and plasma was measured by ELISA at various times after injection. Similar measurements were obtained after immunotoxin was injected into the anterior chamber or subconjunctival space of eyes which had not received vitrectomy. Cultured human retinal pigment epithelial cells were exposed to vitreous fluid obtained after intravitreal injection, and counted after four days, to determine the bioactivity of immunotoxin recovered from vitreous samples. Results. Immunotoxin was cleared rapidly from the vitreous cavity over the first 24 hr (t(1/2) = 8.0 hr), and thereafter was slow. Drug recovered from the vitreous cavity retained significant antiproliferative activity at 96 hr. Immunotoxin was cleared within 6 hr from the aqueous after anterior chamber injection, and was not present inside the eye after subconjunctival injection. The plasma did not contain immunotoxin after any of these injections. Conclusions. The favorable pharmacokinetics of antitransferrin receptor immunotoxin in the rabbit eye suggests that it could be useful in the treatment of ocular proliferative disorders.

Original languageEnglish (US)
Pages (from-to)1039-1044
Number of pages6
JournalCurrent Eye Research
Volume15
Issue number10
StatePublished - Oct 1996
Externally publishedYes

Fingerprint

Immunotoxins
Rabbits
Injections
Anterior Chamber
Pharmacokinetics
Proliferative Vitreoretinopathy
Intravitreal Injections
Trabeculectomy
Retinal Pigments
Eye Diseases
Vitrectomy
Blister
Cicatrix
Gases
Epithelial Cells
Enzyme-Linked Immunosorbent Assay

Keywords

  • Antitransferrin receptor immunotoxin
  • Pharmacokinetics
  • Proliferative vitreoretinopathy
  • Rabbit

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Clearance of antitransferrin receptor immunotoxin from the rabbit eye. / Handa, James; Pearson, P. Andrew; Jaffe, Glenn J.

In: Current Eye Research, Vol. 15, No. 10, 10.1996, p. 1039-1044.

Research output: Contribution to journalArticle

Handa, J, Pearson, PA & Jaffe, GJ 1996, 'Clearance of antitransferrin receptor immunotoxin from the rabbit eye', Current Eye Research, vol. 15, no. 10, pp. 1039-1044.
Handa, James ; Pearson, P. Andrew ; Jaffe, Glenn J. / Clearance of antitransferrin receptor immunotoxin from the rabbit eye. In: Current Eye Research. 1996 ; Vol. 15, No. 10. pp. 1039-1044.
@article{1e193f5c1d4148d2996b4dedf2ee37cb,
title = "Clearance of antitransferrin receptor immunotoxin from the rabbit eye",
abstract = "Purpose. Antitransferrin receptor immunotoxin has potent antiproliferative effects on proliferating human ocular cells in vitro, and shows promise in the treatment of ocular proliferative diseases, such as proliferative vitreoretinopathy, bleb scarring after trabeculectomy, or corneal epithelial downgrowth syndrome. Before treating patients, the pharmacokinetics of immunotoxin must be known. The purpose of this study was to determine the clearance of antitransferrin receptor immunotoxin from the rabbit eye after ocular injection. Methods. Immunotoxin (1,000 ng/0.l ml PBS) was injected into the vitreous cavity of gas vitrectomized rabbit eyes. Immunotoxin in aqueous, vitreous, and plasma was measured by ELISA at various times after injection. Similar measurements were obtained after immunotoxin was injected into the anterior chamber or subconjunctival space of eyes which had not received vitrectomy. Cultured human retinal pigment epithelial cells were exposed to vitreous fluid obtained after intravitreal injection, and counted after four days, to determine the bioactivity of immunotoxin recovered from vitreous samples. Results. Immunotoxin was cleared rapidly from the vitreous cavity over the first 24 hr (t(1/2) = 8.0 hr), and thereafter was slow. Drug recovered from the vitreous cavity retained significant antiproliferative activity at 96 hr. Immunotoxin was cleared within 6 hr from the aqueous after anterior chamber injection, and was not present inside the eye after subconjunctival injection. The plasma did not contain immunotoxin after any of these injections. Conclusions. The favorable pharmacokinetics of antitransferrin receptor immunotoxin in the rabbit eye suggests that it could be useful in the treatment of ocular proliferative disorders.",
keywords = "Antitransferrin receptor immunotoxin, Pharmacokinetics, Proliferative vitreoretinopathy, Rabbit",
author = "James Handa and Pearson, {P. Andrew} and Jaffe, {Glenn J.}",
year = "1996",
month = "10",
language = "English (US)",
volume = "15",
pages = "1039--1044",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Clearance of antitransferrin receptor immunotoxin from the rabbit eye

AU - Handa, James

AU - Pearson, P. Andrew

AU - Jaffe, Glenn J.

PY - 1996/10

Y1 - 1996/10

N2 - Purpose. Antitransferrin receptor immunotoxin has potent antiproliferative effects on proliferating human ocular cells in vitro, and shows promise in the treatment of ocular proliferative diseases, such as proliferative vitreoretinopathy, bleb scarring after trabeculectomy, or corneal epithelial downgrowth syndrome. Before treating patients, the pharmacokinetics of immunotoxin must be known. The purpose of this study was to determine the clearance of antitransferrin receptor immunotoxin from the rabbit eye after ocular injection. Methods. Immunotoxin (1,000 ng/0.l ml PBS) was injected into the vitreous cavity of gas vitrectomized rabbit eyes. Immunotoxin in aqueous, vitreous, and plasma was measured by ELISA at various times after injection. Similar measurements were obtained after immunotoxin was injected into the anterior chamber or subconjunctival space of eyes which had not received vitrectomy. Cultured human retinal pigment epithelial cells were exposed to vitreous fluid obtained after intravitreal injection, and counted after four days, to determine the bioactivity of immunotoxin recovered from vitreous samples. Results. Immunotoxin was cleared rapidly from the vitreous cavity over the first 24 hr (t(1/2) = 8.0 hr), and thereafter was slow. Drug recovered from the vitreous cavity retained significant antiproliferative activity at 96 hr. Immunotoxin was cleared within 6 hr from the aqueous after anterior chamber injection, and was not present inside the eye after subconjunctival injection. The plasma did not contain immunotoxin after any of these injections. Conclusions. The favorable pharmacokinetics of antitransferrin receptor immunotoxin in the rabbit eye suggests that it could be useful in the treatment of ocular proliferative disorders.

AB - Purpose. Antitransferrin receptor immunotoxin has potent antiproliferative effects on proliferating human ocular cells in vitro, and shows promise in the treatment of ocular proliferative diseases, such as proliferative vitreoretinopathy, bleb scarring after trabeculectomy, or corneal epithelial downgrowth syndrome. Before treating patients, the pharmacokinetics of immunotoxin must be known. The purpose of this study was to determine the clearance of antitransferrin receptor immunotoxin from the rabbit eye after ocular injection. Methods. Immunotoxin (1,000 ng/0.l ml PBS) was injected into the vitreous cavity of gas vitrectomized rabbit eyes. Immunotoxin in aqueous, vitreous, and plasma was measured by ELISA at various times after injection. Similar measurements were obtained after immunotoxin was injected into the anterior chamber or subconjunctival space of eyes which had not received vitrectomy. Cultured human retinal pigment epithelial cells were exposed to vitreous fluid obtained after intravitreal injection, and counted after four days, to determine the bioactivity of immunotoxin recovered from vitreous samples. Results. Immunotoxin was cleared rapidly from the vitreous cavity over the first 24 hr (t(1/2) = 8.0 hr), and thereafter was slow. Drug recovered from the vitreous cavity retained significant antiproliferative activity at 96 hr. Immunotoxin was cleared within 6 hr from the aqueous after anterior chamber injection, and was not present inside the eye after subconjunctival injection. The plasma did not contain immunotoxin after any of these injections. Conclusions. The favorable pharmacokinetics of antitransferrin receptor immunotoxin in the rabbit eye suggests that it could be useful in the treatment of ocular proliferative disorders.

KW - Antitransferrin receptor immunotoxin

KW - Pharmacokinetics

KW - Proliferative vitreoretinopathy

KW - Rabbit

UR - http://www.scopus.com/inward/record.url?scp=0029803604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029803604&partnerID=8YFLogxK

M3 - Article

C2 - 8921243

AN - SCOPUS:0029803604

VL - 15

SP - 1039

EP - 1044

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

IS - 10

ER -